Ibrutinib is a BTK inhibitor. It’s designed to fight mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström’s macroglobulinemia. It comes in capsules or tablets, each one’s 140 mg.
You usually take it between 420 and 560 mg, once a day. Each bottle has enough tablets for 90 doses.
